Balyasny Asset Management LLC Zomedica Corp. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding ZOM
# of Institutions
87Shares Held
80.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$6.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.93MShares$1.29 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.28 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$456,2840.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$320,6490.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $127M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...